Aureka Releases Open-Source Engine for Drug Discovery
Aureka has launched OpenDDE, an open-source engine designed to accelerate AI-driven drug discovery. The release aims to speed up the identification of new therapeutic treatments.
Aureka released OpenDDE on Monday, an open-source engine intended to accelerate AI-driven therapeutic discovery. The company stated the release represents a concrete step toward advancing open scientific AI for future biomedical research.
Operating from Laguna Hills, California, and Shanghai, Aureka explained that OpenDDE utilizes an all-atom biomolecular foundation model with co-folding as its entry point for a scalable drug discovery engine. The AI model is designed to identify and design therapeutic compounds more rapidly.
The open-source nature of the software is expected to foster collaboration and innovation within the drug research sector. The emphasis is on speeding up the discovery process for therapeutic agents, potentially shortening the time to market for new medications and improving patient outcomes.
OpenDDE is intended to provide researchers with tools to model complex biological systems and identify new drug targets with greater efficiency than previous methods.